甲胎蛋白阴性肝癌患者血清E-cadherin、TXNIP、DKK1水平及其联合检测对预后的预测价值
李晓娜 , 张金金 , 薛百钊 , 崔静 , 王洪玲
中国医科大学学报 ›› 2026, Vol. 55 ›› Issue (6) : 522 -526.
甲胎蛋白阴性肝癌患者血清E-cadherin、TXNIP、DKK1水平及其联合检测对预后的预测价值
Serum E-cadherin,TXNIP,and DKK1 levels in patients with alpha-fetoprotein-negative hepatocellular carcinoma and their combined prognostic value
目的 探讨甲胎蛋白阴性肝细胞癌(AFP-NHCC)患者血清上皮钙黏蛋白(E-cadherin)、硫氧还蛋白相互作用蛋白(TXNIP)、Dickkopf相关蛋白1(DKK1)水平及其联合检测对预后的预测价值。方法 前瞻性分析我院接受肝癌切除术的295例AFP-NHCC患者的临床资料和术前血清E-cadherin、TXNIP、DKK1水平。随访3年,应用Cox回归分析AFP-NHCC患者预后。结果 BCLC分期B~C期、病理低分化程度、伴肝内淋巴结转移及血清E-cadherin<886.35 μg/L、TXNIP<40.27 pg/mL、DKK1≥9.75 μg/L是影响AFP-NHCC患者预后的危险因素(P < 0.05);与低E-cadherin组、低TXNIP组、高DKK1组及联合高风险组相比,高E-cadherin组、高TXNIP组、低DKK1组及联合低风险组患者的累积生存率更高(均P < 0.05)。结论 血清E-cadherin、TXNIP、DKK1水平与AFP-NHCC预后密切相关,且三者联合检测对患者的预后有较高预测价值。
Objective To investigate the serum epithelial cadherin(E-cadherin),thioredoxin-interacting protein(TXNIP),and Dickkopf-related protein 1(DKK1)levels in patients with alpha-fetoprotein(AFP)-negative hepatocellular carcinoma(NHCC)and their combined prognostic value. Methods The clinical data of 295 patients with AFP-NHCC who underwent liver cancer resection at our hospital and their preoperative serum E-cadherin,TXNIP,and DKK1 levels were retrospectively analyzed. After 3 years of follow-up,the prognosis of the patients with AFP-NHCC was analyzed using Cox regression. Results Cox regression analysis showed that Barcelona Clinic Liver Cancer stage B to C,poor pathological differentiation,intrahepatic lymph node metastasis,and serum levels of E-cadherin(<886.35 μg/L),TXNIP(<40.27 pg/mL),and DK1(≥9.75 μg/L)were prognostic factors in patients with AFP-NHCC(P < 0.05). The Kaplan-Meier curve showed that the high E-cadherin,high TXNIP,low DKK1,and joint low-risk groups had higher cumulative survival rates than the low E-cadherin,low TXNIP,high DKK1,and joint high-risk groups(all P < 0.05). Conclusion Serum E-cadherin,TXNIP,and DKK1 levels are closely associated with the prognosis of AFP-NHCC,and their combination demonstrated high predictive value for patient prognosis.
| [1] |
|
| [2] |
|
| [3] |
HANIF H, |
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
KIELBIK M,SZULC-KIELBIK I,KLINK M. E-cadherin expression in relation to clinicopathological parameters and survival of patients with epithelial ovarian cancer [J]. Int J Mol Sci,2022,23(22):14383. DOI:10.3390/ijms232214383. |
| [8] |
|
| [9] |
|
| [10] |
张霞,罗寰,赵悦, |
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
河北省医学科学研究重点课题计划(20240876)
/
| 〈 |
|
〉 |